Uses of monoclonal antibody 8H9
This invention provides a composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a suitable carrier. This invention provides a pharmaceutical composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a pharmaceutically acceptable carrier. This invention also provides an antibody other than the monoclonal antibody 8H9 comprising the complementary determining regions of monoclonal antibody 8H9 or a derivative thereof, capable of binding to the same antigen as the monoclonal antibody 8H9. This invention provides a substance capable of competitively inhibiting the binding of monoclonal antibody 8H9. This invention also provides an isolated scFv of monoclonal antibody 8H9 or a derivative thereof. This invention also provides the 8H9 antigen. This invention also provides a method of inhibiting the growth of tumor cells comprising contacting said tumor cells with an appropriate amount of monoclonal antibody 8H9 or a derivative thereof.
- Research Organization:
- Sloan-Kettering Inst. for Cancer Research, New York, NY (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- FG02-93ER61658
- Assignee:
- Sloan-Kettering Institute for Cancer Research (New York, NY)
- Patent Number(s):
- 9,938,351
- Application Number:
- 15/365,803
- OSTI ID:
- 1434705
- Country of Publication:
- United States
- Language:
- English
Similar Records
Uses of monoclonal antibody 8H9
Uses of monoclonal antibody 8H9